The Experts

A - M | N - Z

Benjamin Apelberg, PhD, MHS
Johns Hopkins Bloomberg School of Public Health
Dr. Apelberg currently serves as a research associate in both the Epidemiology Department at the Johns Hopkins Bloomberg School of Public Health and at the Institute for Global Tobacco Control. An environmental epidemiologist, he has applied his training to the investigation of the health effects of pervasive environmental toxins, including tobacco smoke. He has conducted studies highlighting the benefits of increasing tobacco use cessation rates in countries such as Japan and the United States. He is currently working to provide investigators with a tool to establish a smoker’s risk for developing disease.

Tobacco Control Surveillance

Douglas Bettcher MD, PhD
Tobacco Free Initiative (WHO)
Douglas Bettcher MD, PhD holds a doctorate in International Relations and a graduate diploma in World Politics, both from the London School of Economics and Political Science; a master’s degree in Public Health (with a focus on developing countries) from the London School of Hygiene and Tropical Medicine; and a doctor of medicine degree from the University of Alberta, Canada. He is currently the director of WHO's Tobacco Free Initiative department in Geneva where he supervises WHO's global program on tobacco control. He also sits on the editorial board of WHO's scientific journal Bulletin of the World Health Organization. Dr Bettcher was Coordinator of the WHO's Framework Convention on Tobacco Control Office in Geneva from 1998 to 2007 and has served as vice-chair of the public health interest group of the American Society of International Law. He is also a member of the editorial board of the journal Global Governance.

The FCTC: An Update

Stella Aguinaga Bialous, RN, MScN, DrPH, FAAN
Tobacco Policy International
Dr. Stella Bialous is the President of Tobacco Policy International which conducts research and provides policy consulting. She is also a senior consultant for the World Health Organization and was a senior consultant on Dr. Linda Sarna's Robert Wood Johnson Foundation-funded “Tobacco Free Nurses” initiative, the first ever national program in the U.S. to help nurses with smoking cessation. Currently she consultants for the Centers for Disease Control and the Prevention-funded “Helping Smokers Quit Project,” assessing strategies to translate evidence-based tobacco dependence treatment into clinical nursing practice. She has published extensively on tobacco industry monitoring, international policy, nursing strategy and tobacco control and has been a speaker at many national and international conferences, participating in the organizing committee of the 2006 and 2009 World Conference on Tobacco or Health. In 2003 she was the first recipient of the American Legacy Foundation's Sybil G. Jacobs Adult Award for Outstanding Use of Tobacco Industry Documents for Public Health.

Corporate Social Responsibility Programs | The Role of Nurses in Tobacco Control

Johanna D. Birckmayer, PhD, MPH
Campaign for Tobacco-Free Kids
Johanna D. Birckmayer received her PhD in Health Policy at Harvard University, completing her dissertation on the effects of changes in alcohol policies on youth violence. She holds a Masters in Public Health from the Department of Health Behavior and Health Education at the University of North Carolina. She has worked in Africa in the design, implementation and evaluation of health programs and in Colorado where she conducted an assessment of county-wide tobacco policies and co-wrote a county tobacco control plan. She was the Program Director at the Pacific Institute for Research and Evaluation in Calverton, Maryland where she conducted analysis of state block grants for the prevention of alcohol, tobacco and other drug-related problems, and is currently the Director of International Research for the Campaign for Tobacco-Free Kids in Washington D.C.

Best Practices in Tobacco Control Policy: An Update

Jose Luis Castro
International Union Against Tuberculosis and Lung Disease
José Luis Castro has an MPA from University of Pennsylvania; an MA from the Teacher’s College at Columbia University and a doctorate in business administration at the International School of Management. He is currently Deputy Executive Director at the International Union Against Tuberculosis and Lung Disease. Mr. Castro formerly worked for the Philadelphia and New York City Departments of Public Health where he helped develop New York’s Municipal Public Health Services Plan which is considered an international model for TB control. He then worked as an advisor to the World Health Organization in India assisting in the implementation of the Revised National TB Control Program. He established the International Management Development Programme in 2003. He is also a member of the board of directors of the World Lung Foundation and Fundación Carlos J. Finlay and serves on the editorial board of the Journal of Health Management.

Resource Development for Tobacco Control

Frank Chaloupka, PhD
University of Illinois and ITEN
Dr. Frank Chaloupka received his BA from John Carroll College in 1984 and his PhD from the City University of New York Graduate School and University Center. He is currently an economics professor at the University of Illinois at Chicago College of Business Administration. He serves as the director of both the International Tobacco Evidence Network and ImpacTeen: A Policy Research Partnership to Reduce Youth Substance Abuse. Dr. Chaloupka is also a research associate in both the Health Economics and Children's Programs of the National Bureau of Economic Research. His areas of research interest include the economic analysis of substance abuse and the effect that control programs have on the demand of substances such as tobacco and alcohol. Dr. Chaloupka has authored many research papers on these subjects and is a major contributor to the research advances in the field of substance abuse economics.

Tobacco Taxation

Sophia Chan, PhD, MPH, MEd, RN, RSCN, FFPH, FAAN
University of Hong Kong
Sophia Chan is currently Professor of Nursing, Head of the Department of Nursing Studies and Assistant Dean of the Li Ka Shing Faculty of Medicine at the University of Hong Kong. She read her Masters of Education at the University of Manchester, Masters of Public Health at the Harvard School of Public Health, and completed doctoral studies at the University of Hong Kong. Chan’s research explores comparative ethno-cultural differences between Chinese and other smokers through the synthesis of epidemiological and social science methodologies. She also examines professional role differentiation among health and social care workers in the delivery of smoking cessation services. Chan pioneered the first smoking cessation counseling program in Hong Kong and has been training medical, nursing, pharmacy, and social work professionals in tobacco dependency treatment interventions throughout China. She also developed a Women Against Tobacco Taskforce (WATT) in Hong Kong to help women smokers quit, and had initiated the first Youth Quitline in Hong Kong.

Setting Up a Smoking Cessation Clinic

Joanna Cohen, PhD
Institute for Global Tobacco Control
Joanna Cohen is the Bloomberg Associate Professor of Disease Prevention and the Director of the Institute for Global Tobacco Control at the Johns Hopkins Bloomberg School of Public Health. She also holds an appointment in the Dalla Lana School of Public Health at the University of Toronto. She obtained her PhD in Health Policy and Administration from the University of North Carolina - Chapel Hill and her MHSc in Community Health and Epidemiology from the University of Toronto. Dr. Cohen researches the factors influencing adoption and implementation of public health policy along with analysis of positive outcomes and unintended consequences. Her studies include analysis of both Canadian and U.S. legislation regarding tobacco and tobacco control policy, a longitudinal cohort of smokers focusing on quitting behavior and outside influences, tobacco promotion at the point of sale, tobacco pricing and taxation, tobacco packaging, options for reducing the physical availability of tobacco products, and tobacco industry interference in tobacco control.

Tobacco Industry: Recent Developments

Greg Connolly, DMD, MPH
Harvard School of Public Health
Greg Connolly currently serves as a Professor of the Practice of Public Health in the Department of Society, Human Health, and Development and Director of the Center for Global Tobacco Control in the Division of Public Health Practice at the Harvard School of Public Health. In addition, he is a scientific adviser for the Massachusetts Department of Public Health. He focuses his research attention to tobacco control and prevention of tobacco-related disease. He is currently the principle investigator for three projects studying varying aspects of tobacco control, from tobacco product design to the efficacy of tobacco control policies. He is a Dr. William Cahan Distinguished Professor awarded to the Harvard School of Public Health by the Flight Attendants Medical Research Institute. Dr. Connolly has published extensively on tobacco control policies.

Developing a Mass Media Anti-Smoking Campaign

Vera Luiza da Costa e Silva, MD, PhD, MBA
National Public Health School, Oswaldo Cruz Foundation
Dr. Vera Luiza Da Costa e Silva is a medical doctor with a PhD in Public Health and Epidemiology and a Masters in Business Administration for the Health Sector. She is currently an associated professor at the National Public Health School, Oswaldo Cruz Foundation (FioCruz) in Brazil. For 16 years she coordinated different activities in the areas of epidemiology and cancer prevention and control at Brazil’s National Cancer Institute and was involved in legislative, economic, surveillance and regulatory tobacco control measures, and in the establishment of a tobacco products regulatory authority. From 2001 to 2005 she was the director of the Tobacco Free Initiative at the World Health Organization-WHO-in Geneva, Switzerland where she supervised the secretariat to the negotiations of the WHO Framework Convention on Tobacco Control. In March 2007, Dr. Costa e Silva joined PAHO as team leader in the tobacco control program.

Developing a National Program: Brazil Case Study

Thomas Frieden, MD, MPH
Centers for Disease Control and Prevention (CDC)
Thomas Frieden is currently the Director of the Centers for Disease Control and Prevention (CDC) and Administrator of the Agency for Toxic Substances and Disease Registry (ATSDR). He formerly served as Commissioner of the New York City Department of Health and Mental Hygiene, one of the world's oldest and largest public health agencies. In 2002, Dr. Frieden launched a citywide anti-tobacco initiative that included raising the local tax on cigarettes and prohibiting smoking in virtually all work spaces, including 20,000 bars and restaurants. Because of his efforts, New York City is a national and global model for tobacco control. A leading expert in tuberculosis control, Dr. Frieden was appointed NYC Health Commissioner after working in India for 5 years, where he helped develop one of the world's most effective tuberculosis control programs. Prior to his tenure in India, Dr. Frieden was instrumental in stopping the tuberculosis epidemic in New York City. Dr. Frieden is considered one of the most respected experts in public health.

How to Prevent 100 Million Deaths From Tobacco

Gary A. Giovino, PhD
SUNY School of Public Health and Health Professions
Gary A. Giovino, PhD serves as Chairman of the Department of Health Behavior at SUNY School of Public Health and Health Professions. He earned his doctoral degree in Experimental Pathology (Epidemiology) at the University at Buffalo. In 1988, he joined the Office on Smoking and Health at the Centers for Disease Control and Prevention (CDC), where he served as Chief of the Epidemiology Branch. In 1999 he became a Senior Research Scientist in the Department of Health Behavior of the Roswell Park Cancer Institute. Dr. Giovino is a member of the New York State Tobacco Control Program Advisory Board. He is Principal Investigator of two Robert Wood Johnson Foundation (RWJF)-funded studies; including a national patterns study of youth smoking cessation and a survey to assess "hardcore" smoking and interest in tobacco harm reduction. He also heads the tobacco team for the ImpacTeen component of the RWJF-funded “Bridging the Gap” project.

Stanton Glantz, PhD
University of California, San Francisco School of Medicine
Stanton Arnold Glantz, PhD is Professor of Medicine (Cardiology), American Legacy Foundation Distinguished Professor of Tobacco Control, and Director of the Center for Tobacco Control Research and Education at the University of California, San Francisco (UCSF) School of Medicine. He is a leading activist in the nonsmokers' rights movement and helped in the defense of the San Francisco Workplace Smoking Ordinance which represented the first electoral defeat of the tobacco industry. He is one of the founders of Americans for Nonsmokers' Rights and author of four books and nearly 300 scientific papers, including the first review identifying involuntary smoking as a cause of heart disease and a landmark review in JAMA showing the tobacco industry knew nicotine was addictive and that smoking caused cancer 30 years earlier. He now runs two projects, and—which counter efforts to exploit smoking in movies and in the hospitality industry.

Best Practices in Tobacco Control Programs: An Update

Jack Henningfield, PhD
Johns Hopkins School of Medicine
Pinney Associates
Dr. Henningfield is Adjunct Professor of Behavioral Biology, Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine, and Vice President for Research and Health Policy at Pinney Associates, a health care consulting firm in Maryland. Dr. Henningfield has investigated addictive drugs, including alcohol, cocaine, marijuana, morphine and nicotine, as well as medications for treating addiction and other disorders. Much of his research was conducted at the National Institute on Drug Abuse where he was a principal investigator and directed several laboratories dedicated to the study of addictive drugs and addiction treatment from 1980 to 1996. Dr. Henningfield continues to serve as advisor and consultant to various departments of the U.S. Federal Government, the World Health Organization and other organizations that address issues of tobacco, drug addiction and health.

Tobacco Addiction

Tei-wei Hu, PhD
University of California
Dr. Hu is currently a professor emeritus in the Health Policy and Management Department at the University of California, Berkeley School of Public Health. He also directs the Center for International Tobacco Control Policy, Research and Evaluation at the Public Health Institute. In February of 2011 Dr. Hu was appointed to a U.S. Centers for Disease Control and Prevention (CDC) committee on smoking and health. His research interests include tobacco control economics and health care reform in Asia. Dr. Hu has published extensively in the field of tobacco control economics, and is considered an expert on the effects that various control policies, such as taxation, have on global tobacco markets.

Economic Analysis of Tobacco Supply

Laurent Huber
Framework Convention Alliance
Laurent Huber is the Director of the Framework Convention Alliance (FCA), an organization that has been active in promoting, creating, and entering into force the international treaty on tobacco control. He is also the Executive Director of Action on Smoking and Health (ASH). Under his leadership these organizations are credited with shaping the international treaty movement, and his actions are generally regarded as being influential in establishing international tobacco control policy. Mr. Huber is considered a leader in the field of Non-Governmental Organization monitoring of tobacco control programming under the World Health Organization Framework Convention on Tobacco Control. He is a recent (2005) recipient of the American Lung Association C. Everett Koop Unsung Hero Award.

The Role of Civil Society in the FCTC Process

Andrew Hyland, PhD
Roswell Park Cancer Institute
Dr. Hyland is an Associate Member in the Department of Health Behavior at Roswell Park Cancer Institute. Dr. Hyland holds a PhD in Epidemiology and a MA in Statistics from the State University of New York at Buffalo. Dr. Hyland’s primary research interests lie in evaluating the impact of policies aimed at reducing the morbidity and mortality associated with the use of tobacco products. Examples of his work include an evaluation of the economic impact of clean indoor air laws, monitoring trends in cancer rates and cancer risk factors in the population using geographical methods, and assessing the impact of a variety of tobacco policy measures on cessation and mortality in large cohorts of smokers in the US and internationally. His recent work has involved facilitating comprehensive evaluations of national and sub-national clean air regulations and examining the impact of low and untaxed cigarette sales on indicators of smoking cessation and uncollected tax revenue.

Evaluating Smoke-Free Policies

Natasha Jategaonkar, MSc
University of British Columbia
Currently a law student at the University of British Columbia, Natasha Jategaonkar worked with the Framework Convention Alliance (FCA) as the Project Manager of the FCA FCTC Monitor between November 2006 and April 2008. The FCA FCTC Monitor is a civil-society-based approach to monitoring and evaluating the implementation of the Framework Convention on Tobacco Control in countries around the world. Previously, she was co-editor of the international report “Turning a New Leaf: Women, Tobacco, and the Future” and for three years conducted community-based research as the Tobacco Research Coordinator with the British Columbia Centre of Excellence for Women’s Health in Vancouver, Canada.

Women and Tobacco

Kelley Lee, DPhil, FFPH
London School of Hygiene & Tropical Medicine
Dr. Kelley Lee is Reader in Global Health, Co-Director of the WHO Collaborating Centre on Global Change and Health, and Head of the Public and Environmental Health Research Unit at the London School of Hygiene and Tropical Medicine. Her research focuses on the impacts of globalisation on communicable and non-communicable diseases, including analysing the internal documents of British American Tobacco to understand market entry strategies, policy influence, cigarette smuggling and other industry tactics. She has authored over 60 scholarly papers, 36 book chapters and 10 books including Globalization and Health, An introduction (Palgrave Macmillan, 2003), Global Change and Health (Open University Press, 2005), and The World Health Organization (Routledge, 2008).

Tobacco Industry Tactics

Sandra Mullin
World Lung Foundation
Sandra Mullin is Senior Vice President for Policy and Communications at World Lung Foundation where she oversees a 17-member team providing assistance to governments and NGOs as part of the Bloomberg Initiative to Reduce Tobacco Use. She has led WLF’s effort to assist countries in mounting mass media tobacco control campaigns, having overseen more than 60 campaigns in nearly 20 countries in her first three years. Ms. Mullin also spent 12 years in New York City government, most recently as Communications Director to New York City Council Speaker Christine C. Quinn. Ms. Mullin assisted in communication strategies for enhancing public safety, securing opportunities for early childhood education and promoting affordable housing and hunger relief. In her prior position as Associate Commissioner and Director of Communications at the New York City Department of Health and Mental Hygiene, she helped push through the Smoke Free Air Act of 2002, which banned smoking in all workplaces, including bars and restaurants.

Communication for Tobacco Control: An Update

Matt Myers, JD
Campaign for Tobacco-Free Kids
Matt Myers currently serves as president and CEO of Campaign for Tobacco Free Kids, an organization that focuses attention on curtailing youth tobacco use. Instrumental in establishing the organization he has been with the Campaign since its creation in 1996. In addition, Mr. Myers played an integral role in settling suits brought against Liggett Tobacco Company and in crafting domestic tobacco control policy. He has been awarded the Harvard School of Public Health’s highest honor, the Julius B. Richmond award, for his work on reducing the tobacco industry’s ability to market to children. As president of the Campaign, he focuses on decreasing the the tobacco industry’s influence over children and countering tobacco industry actions.

Tobacco and Youth